13F Pro quality score
Rank #2,628 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from Cosmos Health Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $65.3M | $-19.1M | -25.6% |
| FY 2024 | 10-K | $54.4M | $-16.2M | -28.6% |
| FY 2023 | 10-K | $53.4M | $-18.5M | -40.9% |
| FY 2022 | 10-K | $50.3M | $-13.8M | -14.8% |
| FY 2021 | 10-K/A | $56.2M | $-8.0M | -8.1% |
| FY 2020 | 10-K/A | $55.4M | $820.8K | 4.9% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Cosmos Health Inc. (COSM) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores COSM at 25.4/100 on a composite quality score built from its SEC filings, placing it at rank #2,628 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (2.8) and balance sheet strength (5.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 29.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Cosmos Health Inc. reports quarterly revenue of $19.0M, net income of $-6.1M, an operating margin of -15.4%. Top institutional holders of COSM by reported 13-F value include UBS Group AG, VANGUARD FIDUCIARY, JANE STREET GROUP, based on the most recent SEC filings. COSM trades on the Nasdaq exchange and files with the SEC under CIK 1474167. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate COSM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cosmos Health Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1474167 →